Technology | Ultrasound Intra-cardiac Echo (ICE) | May 01, 2017

Conavi Medical Receives FDA Clearance for Feature Expansion on Foresight Intracardiac Echocardiography System

System now equipped with color Doppler, 2-D and 3-D measurements, and enhanced 3-D visualization

Conavi Medical Receives FDA Clearance for Feature Expansion on Foresight Intracardiac Echocardiography System

May 1, 2017 — Conavi Medical Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Foresight ICE (intracardiac echo) System expanded feature set. The enhancements include color doppler, pulsed wave doppler, 2-D and 3-D measurements, and electrocardiogram (ECG)-gated 3-D image acquisition. These enhancements are expected to help electrophysiologists and interventional cardiologists in the United States by providing them with the tools to make decisions during minimally invasive cardiovascular procedures.

The system's indication for use has been expanded to include the ability to assess physiology with its new doppler capabilities. This will expand the range of clinical scenarios in which the Foresight ICE System can be used, according to Conavi Medical CEO Brian Courtney, M.D.

The Foresight ICE System is available for electrophysiologists and interventional cardiologists practicing in the U.S. who are seeking to use advanced technology for their intracardiac procedures.

Conavi will be showcasing its new features at the Heart Rhythm Society 2017 conference, May 10-12 in Chicago.

For more information: www.conavi.com

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Overlay Init